Swiss biotech #Pharvaris has reported positive data from a phase 3 trial of its drug for #hereditaryangioedema (HAE), setting up #marketingapplications next year.
@pharmaphorum.bsky.socialExplore
@pharmaphorum.bsky.social
@pharmaphorum.bsky.socialSwiss biotech #Pharvaris has reported positive data from a phase 3 trial of its drug for #hereditaryangioedema (HAE), setting up #marketingapplications next year.